Search - tctmd.com

Displaying 1 - 20 of 121

Sort: Relevancy | Date

Presentation TCT India 2025

Role of Imaging / Physiology in ACS – Critical appraisal of current data

Presenter: S. Mullasari Ajit

July 26, 2025

Presentation TCT India 2025

Microvascular Angina - How to Identify, Diagnose, and Manage

Presenter: Ajar Kochar

July 26, 2025

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Daily News

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Caitlin E. Cox

May 29, 2024

News Conference News EuroPCR 2024

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Caitlin E. Cox

May 20, 2024

News Conference News EuroPCR 2024

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

Caitlin E. Cox

May 14, 2024

News Daily News

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

Michael O'Riordan

November 24, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

Michael O'Riordan

September 21, 2023

News Daily News

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

Caitlin E. Cox

September 18, 2023

News Daily News

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Michael O'Riordan

September 13, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Michael O'Riordan

July 18, 2023

News Daily News

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Michael O'Riordan

March 31, 2023

Presentation ACC 2023

Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: a Multimodality Imaging Study (YELLOW III)

Presenter: Annapoorna S. Kini

March 06, 2023

News Daily News

FFR Pullback Measure Linked to Likelihood of Angina Relief After PCI

Todd Neale

December 02, 2022

News Conference News ESC 2022

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

Todd Neale

August 29, 2022

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

News Conference News ACC 2022

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Michael O'Riordan

April 06, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

Advertisement

Role of Imaging / Physiology in ACS – Critical appraisal of current data

Microvascular Angina - How to Identify, Diagnose, and Manage

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

With ANOCA, Better to Test Coronary Function in Multiple Vessels

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: a Multimodality Imaging Study (YELLOW III)

FFR Pullback Measure Linked to Likelihood of Angina Relief After PCI

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content